Mild cognitive impairment cases affect the predictive power of Alzheimers disease diagnostic models using routine clinical variables
Finney, C. A.; Alzheimer's Disease Neuroimaging Initiative, ; Shvetcov, A.
Show abstract
Diagnostic models using primary care routine clinical variables have been limited in their ability to identify Alzheimers disease (AD) patients. In this study we sought to better understand the effect of mild cognitive impairment (MCI) on the predictive performance of AD diagnostic models. We sourced data from the Alzheimers Disease Neuroimaging Initiative (ADNI) cohort. CatBoost was used to assess the utility of routine clinical variables that are accessible to primary care physicians, such as hematological and blood tests and medical history, in multiclass classification between healthy controls, MCI, and AD. Our results indicated that MCI indeed affected the predictive performance of AD diagnostic models. Of three subgroups of MCI that we found, this finding was driven by a subgroup of MCI patients that likely have prodromal AD. Future research should focus on distinguishing MCI from prodromal AD as the utmost priority for improving translational AD diagnostic models for primary care physicians.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease 96%
- Polygenic effects on the risk of Alzheimer’s disease in the Japanese population 95%
- Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults 95%
Similar papers in this journal
- Continuous Associations Between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer’s Disease 96%
- A conformational variant of p53 (U-p53 AZ ) as blood-based biomarker for the prediction of the onset of symptomatic Alzheimer’s disease 95%
- Using Machine Learning and Electronic Health Record (EHR) Data for the Early Prediction of Alzheimer’s Disease and Related Dementias 94%
Similar papers in this journal
- Quantitative longitudinal predictions of Alzheimer's disease by multi-modal predictive learning 95%
- Targeted Serum Metabolomic Profiling and Machine Learning Approach in Alzheimer’s Disease using the Alzheimer’s Disease Diagnostics Clinical Study (ADDIA) Cohort 94%
- Profiles of cognitive change in preclinical Alzheimer's disease using change-point analysis 94%